Menzel Garry E Insider Trading
Get the latest insider transactions of Menzel Garry E. Menzel Garry E is COO & Executive VP, Finance in Regulus Therapeutics Inc. ($RGLS) and Director in Stoke Therapeutics, Inc. ($STOK) and Director in Black Diamond Therapeutics, Inc. ($BDTX) and President & CEO in TCR2 THERAPEUTICS INC. ($TCRR) and President and CEO in TCR2 THERAPEUTICS INC. ($TCRR). Discover the current value of Menzel Garry E shares.
Address: C/O REGULUS THERAPEUTICS INC. 3545 JOHN HOPKINS COURT, SUITE 210 SAN DIEGO 92121CA
Menzel Garry E is Insider in these Companies
| Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
|---|---|---|---|---|
| RGLS | Regulus Therapeutics Inc. | COO & Executive VP, Finance | 0 | 0.00 |
| TCRR | TCR2 THERAPEUTICS INC. | President and CEO, President & CEO | 3,399 | |
| BDTX | Black Diamond Therapeutics, Inc. | Director | 51,825 | |
| STOK | Stoke Therapeutics, Inc. | Director | 0 |
Insider Trading Transactions of Menzel Garry E
| Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
|---|---|---|---|---|---|---|---|---|---|
| Jun 22 2021 | BDTX | Black Diamond Therapeutic ... | Menzel Garry E | Director | Option Exercise | 12.55 | 15,000 | 188,250 | 15,000 |
| Apr 23 2021 | BDTX | Black Diamond Therapeutic ... | Menzel Garry E | Director | Option Exercise | 24.33 | 14,921 | 363,028 | 14,921 |
| Apr 23 2021 | BDTX | Black Diamond Therapeutic ... | Menzel Garry E | Director | Option Exercise | 24.33 | 14,921 | 363,028 | 14,921 |
| Mar 08 2021 | TCRR | TCR2 THERAPEUTICS INC. | Menzel Garry E | President and CEO | Buy | 10.10 | 1,132 | 11,431 | 3,399 |
| Mar 08 2021 | TCRR | TCR2 THERAPEUTICS INC. | Menzel Garry E | President and CEO | Buy | 16.12 | 686 | 11,061 | 4,085 |
| Jan 27 2021 | STOK | Stoke Therapeutics, Inc. | Menzel Garry E | Director | Option Exercise | 28.57 | 29,555 | 844,386 | 29,555 |
| Dec 11 2020 | TCRR | TCR2 THERAPEUTICS INC. | Menzel Garry E | President and CEO | Option Exercise | 31.38 | 245,000 | 7,688,100 | 245,000 |
| Mar 27 2020 | TCRR | TCR2 THERAPEUTICS INC. | Menzel Garry E | President & CEO | Buy | 12.75 | 980 | 12,495 | 980 |
| Mar 27 2020 | TCRR | TCR2 THERAPEUTICS INC. | Menzel Garry E | President & CEO | Buy | 10.10 | 1,287 | 12,999 | 2,267 |
| Feb 05 2020 | BDTX | Black Diamond Therapeutic ... | Menzel Garry E | Director | Buy | 0.00 | 51,825 | 0 | 51,825 |
| Feb 05 2020 | BDTX | Black Diamond Therapeutic ... | Menzel Garry E | Director | Option Exercise | 0.00 | 156,297 | 0 | 0 |
| Dec 20 2019 | TCRR | TCR2 THERAPEUTICS INC. | Menzel Garry E | President and CEO | Option Exercise | 16.10 | 168,000 | 2,704,800 | 168,000 |
| Apr 12 2019 | TCRR | TCR2 THERAPEUTICS INC. | Menzel Garry E | President & CEO | Option Exercise | 16.11 | 486,106 | 7,831,168 | 486,106 |
| Dec 13 2012 | RGLS | Regulus Therapeutics Inc. | Menzel Garry E | COO & Executive VP, F ... | Option Exercise | 4.44 | 75,000 | 333,000 | 75,000 |